Journal
CLINICAL NEUROLOGY AND NEUROSURGERY
Volume 140, Issue -, Pages 47-51Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.clineuro.2015.11.008
Keywords
Heat shock protein; Tuberculous meningitis; Mycobacterium tuberculosis; Cerebrospinal fluid; Diagnosis; Biomarker
Categories
Funding
- Indian Council of Medical Research, Government of India, New Delhi, India [5/8/5/1/2007-ECD-I]
Ask authors/readers for more resources
Objectives: Diagnosis of tuberculosis meningitis (TBM) remains challenging in tuberculosis (TB) endemic countries. The need for TB biomarkers arises, in part, from the difficulty of accurately diagnosing TBM with the available methods. Patients and methods: To explore the potential of host Hsps (Hsp 25, Hsp 60, Hsp 70 and Hsp 90) as an alternative marker in TBM diagnosis, we evaluated cerebrospinal fluid (CSF) sample of TBM (n = 49), Pyogenic Meningitis (PM) (n = 20), Viral Meningitis (VM) (n = 09), Fungal Meningitis (FM) (n = 04) and non infectious control (n = 79) patients using indirect ELISA. Results: Out of four Hsps, Hsp 70 and Hsp 90 yields 89% & 88% sensitivity and 82% & 89% specificity, respectively. The positive (PPV) and negative (NPV) predictive values yielded in TBM group for Hsp 70 was 86.27% (73.74-94.27) and 93.51% (85.48-97.83), respectively. For Hsp 90 the obtained PPV was 89.36% (76.88-96.41) and NPV was 91.36% (82.99-96.44). In 86% of TBM patients all the four Hsps were found to be positive and none of the patient was found to be negative for all Hsps in the same group. Conclusions: The data presented in the study indicate that host Hsp 70 and Hsp 90 shows good sensitivity and specificity and have potential in the diagnosis of TBM disease. The combined use of all Hsps (Hsp 25, Hsp 60, Hsp 70 and Hsp 90) effectively distinguishes patients with TBM from other disease controls. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available